{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:05:46Z","timestamp":1789473946483,"version":"build-2803163510"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.critrevonc.2026.105462","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:30:04Z","timestamp":1782851404000},"page":"105462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Opportunities and challenges of dihydrodiol dehydrogenase expression in hepatocellular carcinoma"],"prefix":"10.1016","volume":"225","author":[{"given":"Yong","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7976-8264","authenticated-orcid":false,"given":"Hongya","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dehao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijie","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazhou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6793-7119","authenticated-orcid":false,"given":"Jiahao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105462_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.plantsci.2012.07.014","article-title":"Flavonoids as antioxidants in plants: location and functional significance","volume":"196","author":"Agati","year":"2012","journal-title":"Plant. Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105462_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004752","article-title":"Glutathione peroxidase 2 is a metabolic driver of the tumor immune microenvironment and immune checkpoint inhibitor response","volume":"10","author":"Ahmed","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105462_bib3","article-title":"Folated-nanocarrier for paclitaxel drug delivery in leukemia cancer therapy","volume":"10","author":"Al-Musawi","year":"2018","journal-title":"J. Pharm. Sci. Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib4","doi-asserted-by":"crossref","DOI":"10.1063\/5.0092330","article-title":"Nanoformulation of intelligence polymeric nanocarrier for resveratrol targeted delivery and study its cytotoxic, apoptotic, and genetics effects in epidermoid carcinoma therapy","volume":"2437","author":"Alnasraui","year":"2022","journal-title":"AIP Conf. Proc."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105462_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/antiox10050642","article-title":"Oxidative stress in cancer cell metabolism","volume":"10","author":"Arfin","year":"2021","journal-title":"Antioxidants"},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105462_bib6","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/j.febslet.2006.06.046","article-title":"Coffee inhibits the reactivation of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: a glucocorticoid connection in the anti-diabetic action of coffee?","volume":"580","author":"Atanasov","year":"2006","journal-title":"FEBS Lett."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105462_bib7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026062","article-title":"Tumor-suppressor functions of the TP53 pathway","volume":"6","author":"Aubrey","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib8","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1038\/s41598-022-05785-9","article-title":"AKR1C1\/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin","volume":"12","author":"Badmann","year":"2022","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105462_bib9","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.21037\/tcr-21-629","article-title":"The interplay between reactive oxygen species and antioxidants in cancer progression and therapy: a narrative review","volume":"10","author":"Bekhet","year":"2021","journal-title":"Transl. Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105462_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201600235","article-title":"Targeting the SASP to combat ageing: mitochondria as possible intracellular allies?","volume":"39","author":"Birch","year":"2017","journal-title":"Bioessays"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53370-4","article-title":"The transcriptional regulator CBX2 and ovarian function: a whole genome and whole transcriptome approach","volume":"9","author":"Bouazzi","year":"2019","journal-title":"Sci. Rep."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105462_bib12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsbmb.2010.11.004","article-title":"Inhibitors of type 5 17\u03b2-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights","volume":"125","author":"Byrns","year":"2011","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105462_bib13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.bcp.2007.09.008","volume":"75","author":"Byrns","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib14","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/4572660","article-title":"Scutellaria baicalensis in the treatment of hepatocellular carcinoma: network pharmacology analysis and experimental validation","volume":"2023","author":"Cai","year":"2023","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105462_bib15","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s00018-008-7508-5","article-title":"Structural and functional features of dimeric dihydrodiol dehydrogenase","volume":"65","author":"Carbone","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"issue":"10504","key":"10.1016\/j.critrevonc.2026.105462_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S0140-6736(25)01042-6","article-title":"The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment","volume":"406","author":"Chan","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.critrevonc.2026.105462_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cca.2014.08.015","article-title":"Mechanisms of p53 degradation","volume":"438","author":"Chao","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.critrevonc.2026.105462_bib18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2147\/JHC.S283840","article-title":"Understanding the role of metabolic syndrome as a risk factor for hepatocellular carcinoma","volume":"9","author":"Chavez-Tapia","year":"2022","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.critrevonc.2026.105462_bib19","article-title":"The underlying regulatory mechanisms of colorectal carcinoma by combining Vitexin and Aspirin: based on systems biology, molecular docking, molecular dynamics simulation, and in vitro study","volume":"14","author":"Chen","year":"2023","journal-title":"Front. Endocrinol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00280-007-0554-0","article-title":"Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells","volume":"61","author":"Chen","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib21","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s00280-015-2739-2","article-title":"Cisplatin resistance in human cervical, ovarian and lung cancer cells","volume":"75","author":"Chen","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib22","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mc.23527","article-title":"AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP\/SLC7A11 signaling pathway","volume":"62","author":"Chen","year":"2023","journal-title":"Mol. Carcinog."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105462_bib23","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/s41419-022-05408-1","article-title":"Mutant p53 in cancer: from molecular mechanism to therapeutic modulation","volume":"13","author":"Chen","year":"2022","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105462_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103195","article-title":"Iron accumulation in ovarian microenvironment damages the local redox balance and oocyte quality in aging mice","volume":"73","author":"Chen","year":"2024","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3892\/ijmm.2013.1441","article-title":"Extracts of Koelreuteria henryi Dummer induce apoptosis and autophagy by inhibiting dihydrodiol dehydrogenase, thus enhancing anticancer effects","volume":"32","author":"Chiang","year":"2013","journal-title":"Int. J. Mol. Med."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105462_bib26","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-25-2944","article-title":"Targeting tumor-associated macrophages and cancer-associated fibroblasts to overcome therapeutic resistance in hepatocellular carcinoma","volume":"32","author":"Cho","year":"2026","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/cdd.2011.142","article-title":"POZ\/BTB and AT-hook-containing zinc finger protein 1 (PATZ1) inhibits endothelial cell senescence through a p53 dependent pathway","volume":"19","author":"Cho","year":"2012","journal-title":"Cell. Death Differ."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jdermsci.2005.11.007","article-title":"Expression of dihydrodiol dehydrogenase plays important roles in apoptosis- and drug-resistance of A431 squamous cell carcinoma","volume":"41","author":"Chow","year":"2006","journal-title":"J. Dermatol. Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/biom10030361","article-title":"Mutant p53-associated molecular mechanisms of ROS regulation in cancer cells","volume":"10","author":"Cordani","year":"2020","journal-title":"Biomolecules"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105462_bib30","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1158\/0008-5472.CAN-08-4533","article-title":"AKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effects","volume":"69","author":"Davies","year":"2009","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105462_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13112602","article-title":"Vitexin as a potential antidysmenorrheic agent: development of a ZIF-8-based immediate-release system and evaluation via in vivo and in silico approaches","volume":"13","author":"de Alencar Filho","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib32","doi-asserted-by":"crossref","first-page":"6269","DOI":"10.1038\/s41467-023-41852-z","article-title":"URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers","volume":"14","author":"Ding","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib33","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1042\/bj1380425","article-title":"Regulation of the pentose phosphate cycle","volume":"138","author":"Eggleston","year":"1974","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib34","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105462_bib35","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1093\/nar\/gkae811","article-title":"p53-dependent crosstalk between DNA replication integrity and redox metabolism mediated through a NRF2-PARP1 axis","volume":"52","author":"Elfar","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"10127","key":"10.1016\/j.critrevonc.2026.105462_bib36","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib37","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41588-024-02039-4","article-title":"Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations","volume":"57","author":"Funk","year":"2025","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043441","article-title":"Tumor mutational burden for predicting prognosis and therapy outcome of hepatocellular carcinoma","volume":"24","author":"Gabbia","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105462_bib39","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1021\/acs.chemrestox.0c00130","article-title":"PARP1 is required for ATM-mediated p53 activation and p53-mediated gene expression after ionizing radiation","volume":"33","author":"Gajewski","year":"2020","journal-title":"Chem. Res. Toxicol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib40","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1089\/ars.2010.3504","article-title":"Mitochondrial liaisons of p53","volume":"15","author":"Galluzzi","year":"2011","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib41","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.21037\/jgo-23-277","article-title":"AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma","volume":"14","author":"Gao","year":"2023","journal-title":"J. Gastrointest. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib42","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccell.2016.05.020","article-title":"Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma","volume":"30","author":"Gomes","year":"2016","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105462_bib43","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nrd4002","article-title":"Modulation of oxidative stress as an anticancer strategy","volume":"12","author":"Gorrini","year":"2013","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.canlet.2009.02.057","article-title":"The aflatoxin-induced TP53 mutation at codon 249 (R249S): biomarker of exposure, early detection and target for therapy","volume":"286","author":"Gouas","year":"2009","journal-title":"Cancer Lett."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105462_bib45","first-page":"4469","article-title":"Redox modulation of p53 conformation and sequence-specific DNA binding in vitro","volume":"53","author":"Hainaut","year":"1993","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105462_bib46","doi-asserted-by":"crossref","DOI":"10.3390\/cells14100713","article-title":"Molecular Targets of Oxidative Stress: Focus on Nuclear Factor Erythroid 2-Related Factor 2 Function in Leukemia and Other Cancers","volume":"14","author":"Hasan","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105462_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/4055209","article-title":"Zingiberensis Newsaponin Inhibits the Malignant Progression of Hepatocellular Carcinoma via Suppressing Autophagy Moderated by the AKR1C1-Mediated JAK2\/STAT3 Pathway","volume":"2021","author":"He","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105462_bib48","doi-asserted-by":"crossref","first-page":"5104","DOI":"10.1158\/1078-0432.CCR-23-0060","article-title":"Lenvatinib, Toripalimab plus FOLFOX Chemotherapy in Hepatocellular Carcinoma Patients with Extrahepatic Metastasis: A Biomolecular Exploratory, Phase II Trial (LTSC)","volume":"29","author":"He","year":"2023","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105462_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123491","article-title":"Defect in Ser312 phosphorylation of Tp53 dysregulates lipid metabolism for fatty accumulation and fatty liver susceptibility: Revealed by lipidomics","volume":"1211","author":"He","year":"2022","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105462_bib50","first-page":"756","article-title":"Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation","volume":"74","author":"Heidelbaugh","year":"2006","journal-title":"Am. Fam. Physician"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188556","article-title":"Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting","volume":"1876","author":"Hern\u00e1ndez Borrero","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105462_bib52","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.canlet.2006.10.013","article-title":"Cooperative cytotoxicity of methyl jasmonate with anti-cancer drugs and 2-deoxy-D-glucose","volume":"250","author":"Heyfets","year":"2007","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.taap.2014.04.027","article-title":"Anthracycline resistance mediated by reductive metabolism in cancer cells: The role of aldo-keto reductase 1C3","volume":"278","author":"Hofman","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib54","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.taap.2014.04.027","article-title":"Anthracycline resistance mediated by reductive metabolism in cancer cells: the role of aldo-keto reductase 1C3","volume":"278","author":"Hofman","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105462_bib55","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0006-291X(76)91164-5","article-title":"Regulation of pentose phosphate pathway dehydrogenases by NADP+\/NADPH ratios","volume":"68","author":"Holten","year":"1976","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105462_bib56","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1042\/EBC20210090","article-title":"Salicylic acid and jasmonic acid crosstalk in plant immunity","volume":"66","author":"Hou","year":"2022","journal-title":"Essays Biochem."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105462_bib57","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1177\/1535370216641787","article-title":"Role of mitochondrial dysfunction in cancer progression","volume":"241","author":"Hsu","year":"2016","journal-title":"Exp. Biol. Med. (Maywood)"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib58","first-page":"2727","article-title":"Overexpression of dihydrodiol dehydrogenase as a prognostic marker of non-small cell lung cancer","volume":"61","author":"Hsu","year":"2001","journal-title":"Cancer Res."},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105462_bib59","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1158\/0008-5472.CAN-21-4140","article-title":"Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3-ABCB1 Signaling in Hepatocellular Carcinoma","volume":"82","author":"Hu","year":"2022","journal-title":"Cancer Res."},{"issue":"39","key":"10.1016\/j.critrevonc.2026.105462_bib60","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1038\/s41388-023-02757-9","article-title":"A positive feedback between cholesterol synthesis and the pentose phosphate pathway rather than glycolysis promotes hepatocellular carcinoma","volume":"42","author":"Hu","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105462_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.119519","article-title":"Integrated multi-Omics and network toxicology elucidate the multi-target mechanisms of environmental hormones in driving hepatocellular carcinoma","volume":"309","author":"Huang","year":"2026","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105462_bib62","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.7150\/ijbs.69969","article-title":"Genome-Wide CRISPR\/Cas9 Library Screening Identified that DUSP4 Deficiency Induces Lenvatinib Resistance in Hepatocellular Carcinoma","volume":"18","author":"Huang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3164\/jcbn.10-24","article-title":"Antineoplastic effects of gamma linolenic Acid on hepatocellular carcinoma cell lines","volume":"47","author":"Itoh","year":"2010","journal-title":"J. Clin. Biochem. Nutr."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib64","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.18632\/oncotarget.13904","article-title":"Oxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesis","volume":"8","author":"Ivanov","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib65","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ncb2172","article-title":"p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase","volume":"13","author":"Jiang","year":"2011","journal-title":"Nat. Cell. Biol."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105462_bib66","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s13238-014-0082-8","article-title":"Regulation of the pentose phosphate pathway in cancer","volume":"5","author":"Jiang","year":"2014","journal-title":"Protein Cell."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105462_bib67","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v16.i8.109419","article-title":"Combination therapy reduces transarterial chemoembolization resistance in advanced hepatocellular carcinoma","volume":"16","author":"Jiao","year":"2025","journal-title":"World J. Clin. Oncol."},{"issue":"Pt 22","key":"10.1016\/j.critrevonc.2026.105462_bib68","first-page":"5578","article-title":"Mutant p53R273H attenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species","volume":"125","author":"Kalo","year":"2012","journal-title":"J. Cell. Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105462_bib69","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1124\/dmd.108.022251","article-title":"Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver","volume":"36","author":"Kassner","year":"2008","journal-title":"Drug. Metab. Dispos."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040659","article-title":"Doxorubicin-An Agent with Multiple Mechanisms of Anticancer Activity","volume":"12","author":"Kciuk","year":"2023","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib71","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.semcancer.2005.04.003","article-title":"Plasma free amino acid profile in cancer patients","volume":"15","author":"Lai","year":"2005","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib72","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.32802","article-title":"TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk","volume":"78","author":"Lam","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib73","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1038\/s41467-024-50157-8","article-title":"Glucose-6-phosphate dehydrogenase maintains redox homeostasis and biosynthesis in LKB1-deficient KRAS-driven lung cancer","volume":"15","author":"Lan","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib74","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/sj.cdd.4401916","article-title":"Transcriptional regulation by p53: one protein, many possibilities","volume":"13","author":"Laptenko","year":"2006","journal-title":"Cell. Death Differ."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105462_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/biom11081107","article-title":"Phytochemicals in Cancer Immune Checkpoint Inhibitor Therapy","volume":"11","author":"Lee","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2026.105462_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2026.126628","article-title":"Functional doxorubicin and iron ions dual-loaded carboxymethyl chitin-based microspheres for hepatocellular carcinoma therapy via embolization, ferroptosis, and autophagy-mediated HIF-1\u03b1 inhibition","volume":"692","author":"Leng","year":"2026","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib77","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1177\/1087057115603310","article-title":"High-Content Functional Screening of AEG-1 and AKR1C2 for the Promotion of Metastasis in Liver Cancer","volume":"21","author":"Li","year":"2016","journal-title":"J. Biomol. Screen."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib78","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12943-026-02578-w","article-title":"Metabolic reprogramming-driven resistance to multi-kinase inhibitors in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities","volume":"25","author":"Li","year":"2026","journal-title":"Mol. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105462_bib79","first-page":"1295","article-title":"Study on mechanism of icariin-induced ferroptosis in HepG2 hepatoma carcinoma cells through PPARG\/FABP4\/GPX4 pathway","volume":"49","author":"Li","year":"2024","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105462_bib80","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s43018-020-0086-7","article-title":"Aldolase B suppresses hepatocellular carcinogenesis by inhibiting G6PD and pentose phosphate pathways","volume":"1","author":"Li","year":"2020","journal-title":"Nat. Cancer"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105462_bib81","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s42255-024-01060-5","article-title":"ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response","volume":"6","author":"Lim","year":"2024","journal-title":"Nat. Metab."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105462_bib82","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1158\/1535-7163.MCT-18-1322","article-title":"AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105462_bib83","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012230","article-title":"Lactylation-driven MVP upregulation boosts immunotherapy resistance by inhibiting PD-L1 degradation in hepatocellular carcinoma","volume":"13","author":"Liu","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105462_bib84","doi-asserted-by":"crossref","first-page":"11305","DOI":"10.1021\/acs.jmedchem.9b02138","article-title":"Overview of AKR1C3: Inhibitor Achievements and Disease Insights","volume":"63","author":"Liu","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib85","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0959-437X(02)00013-8","article-title":"Tumor suppression by Ink4a-Arf: progress and puzzles","volume":"13","author":"Lowe","year":"2003","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105462_bib86","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/1873-3468.14993","article-title":"Nrf2 as a regulator of energy metabolism and mitochondrial function","volume":"598","author":"Luchkova","year":"2024","journal-title":"FEBS Lett."},{"key":"10.1016\/j.critrevonc.2026.105462_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117664","article-title":"Zingiberensis new saponin reverses sorafenib resistance by targeting lncRNA TCONS-00026762\/AKR1C1 and modulating autophagy and ferroptosis in hepatocellular carcinoma","volume":"507","author":"Luo","year":"2026","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2025.117664","article-title":"Zingiberensis new saponin reverses sorafenib resistance by targeting lncRNA TCONS-00026762\/AKR1C1 and modulating autophagy and ferroptosis in hepatocellular carcinoma","volume":"507","author":"Luo","year":"2026","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib89","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176345","article-title":"Alcohol-associated liver disease","volume":"134","author":"Mackowiak","year":"2024","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105462_bib90","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrc2730","article-title":"The expanding universe of p53 targets","volume":"9","author":"Menendez","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib91","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13046-024-02943-x","article-title":"Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote cervical cancer progression","volume":"43","author":"Meng","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105462_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.932154","article-title":"Recent findings in the regulation of G6PD and its role in diseases","volume":"13","author":"Meng","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib93","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/1479-7364-3-4-362","article-title":"Aldo-keto reductase (AKR) superfamily: genomics and annotation","volume":"3","author":"Mindnich","year":"2009","journal-title":"Hum. Genom."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib94","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","article-title":"Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming","volume":"22","author":"Mitsuishi","year":"2012","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105462_bib95","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.semcdb.2017.05.023","article-title":"ROS signalling in the biology of cancer","volume":"80","author":"Moloney","year":"2018","journal-title":"Semin. Cell. Dev. Biol."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105462_bib96","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202002486RR","article-title":"TCF19 and p53 regulate transcription of TIGAR and SCO2 in HCC for mitochondrial energy metabolism and stress adaptation","volume":"35","author":"Mondal","year":"2021","journal-title":"Faseb J."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105462_bib97","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1038\/cdd.2013.52","article-title":"p53 regulates a non-apoptotic death induced by ROS","volume":"20","author":"Montero","year":"2013","journal-title":"Cell. Death Differ."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib98","doi-asserted-by":"crossref","DOI":"10.3390\/jox15040096","article-title":"Cooperation Between Aflatoxin-Induced p53 Aberrations and Hepatitis B Virus in Hepatocellular Carcinoma","volume":"15","author":"Moreno-Le\u00f3n","year":"2025","journal-title":"J. Xenobiot."},{"key":"10.1016\/j.critrevonc.2026.105462_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1036562","article-title":"Construction of a lipid metabolism-related risk model for hepatocellular carcinoma by single cell and machine learning analysis","volume":"14","author":"Mou","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib100","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1038\/s41467-022-29960-8","article-title":"Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages","volume":"13","author":"Ng","year":"2022","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105462_bib101","doi-asserted-by":"crossref","first-page":"13291","DOI":"10.1074\/jbc.R900010200","article-title":"The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress","volume":"284","author":"Nguyen","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105462_bib102","doi-asserted-by":"crossref","first-page":"9873","DOI":"10.1074\/jbc.M111.312694","article-title":"Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis","volume":"287","author":"Niture","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib103","doi-asserted-by":"crossref","first-page":"a001008","DOI":"10.1101\/cshperspect.a001008","article-title":"TP53 mutations in human cancers: origins, consequences, and clinical use","volume":"2","author":"Olivier","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"157","key":"10.1016\/j.critrevonc.2026.105462_bib104","first-page":"247","article-title":"TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer","author":"Olivier","year":"2004","journal-title":"IARC Sci. Publ."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105462_bib105","doi-asserted-by":"crossref","first-page":"a001107","DOI":"10.1101\/cshperspect.a001107","article-title":"Mutant p53 gain-of-function in cancer","volume":"2","author":"Oren","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105462_bib106","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gene.2010.03.006","article-title":"The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene","volume":"459","author":"Pallai","year":"2010","journal-title":"Gene"},{"issue":"31","key":"10.1016\/j.critrevonc.2026.105462_bib107","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.1038\/s41388-022-02379-7","article-title":"AKR1C3 regulated by NRF2\/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma","volume":"41","author":"Pan","year":"2022","journal-title":"Oncogene"},{"issue":"39","key":"10.1016\/j.critrevonc.2026.105462_bib108","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1038\/s41388-025-03560-4","article-title":"NRF2 immunobiology in cancer: implications for immunotherapy and therapeutic targeting","volume":"44","author":"Panda","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2026.105462_bib109","doi-asserted-by":"crossref","DOI":"10.1093\/carcin\/bgag040","article-title":"Wnt\/\u03b2-catenin Signaling in Hepatocellular Carcinoma: A Major Context-Dependent Contributor to Resistance to Tyrosine Kinase Inhibitors and Immune Checkpoint Inhibitors","author":"Park","year":"2026","journal-title":"Carcinogenesis"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105462_bib110","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tibs.2014.06.005","article-title":"The pentose phosphate pathway and cancer","volume":"39","author":"Patra","year":"2014","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-2797(93)03203-7","article-title":"Dihydrodiol dehydrogenase and its role in polycyclic aromatic hydrocarbon metabolism","volume":"89","author":"Penning","year":"1993","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.critrevonc.2026.105462_bib112","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cbi.2014.09.024","article-title":"The aldo-keto reductases (AKRs): Overview","volume":"234","author":"Penning","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib113","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1021\/acs.chemrestox.6b00319","article-title":"Aldo-Keto Reductase Regulation by the Nrf2 System: Implications for Stress Response, Chemotherapy Drug Resistance, and Carcinogenesis","volume":"30","author":"Penning","year":"2017","journal-title":"Chem. Res. Toxicol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib114","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/tx980143n","article-title":"Dihydrodiol Dehydrogenases and Polycyclic Aromatic Hydrocarbon Activation:\u2009Generation of Reactive and Redox Active o-Quinones","volume":"12","author":"Penning","year":"1999","journal-title":"Chem. Res. Toxicol."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105462_bib115","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.mce.2003.11.006","article-title":"Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins","volume":"215","author":"Penning","year":"2004","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib116","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1124\/pharmrev.120.000122","article-title":"Aldo-Keto Reductases and Cancer Drug Resistance","volume":"73","author":"Penning","year":"2021","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib117","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10637-017-0443-2","article-title":"Metabolic carbonyl reduction of anthracyclines - role in cardiotoxicity and cancer resistance. Reducing enzymes as putative targets for novel cardioprotective and chemosensitizing agents","volume":"35","author":"Piska","year":"2017","journal-title":"Invest. New. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105462_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.mito.2024.101889","article-title":"Image-based quantification of mitochondrial iron uptake via Mitoferrin-2","volume":"78","author":"Polesel","year":"2024","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib119","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/s41419-025-08105-x","article-title":"Resistance of first-line targeted drugs in hepatocellular carcinoma: the epigenetic regulation mechanisms","volume":"16","author":"Qi","year":"2025","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105462_bib120","doi-asserted-by":"crossref","DOI":"10.1111\/cas.70403","article-title":"AKR1C3 Binds \u03b2-Trcp to Promote the Degradation of TFRC to Protect Hepatocellular Carcinoma From Ferroptosis","author":"Qi","year":"2026","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soc.2023.06.004","article-title":"Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide","volume":"33","author":"Rich","year":"2024","journal-title":"Surg. Oncol. Clin. N. Am."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105462_bib122","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165356","article-title":"Adjuvant COX inhibition augments STING signaling and cytolytic T cell infiltration in irradiated 4T1 tumors","volume":"9","author":"Ridnour","year":"2024","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105462_bib123","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jhep.2023.03.003","article-title":"Combination immunotherapy for hepatocellular carcinoma","volume":"79","author":"Rimassa","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib124","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.freeradbiomed.2023.07.022","article-title":"p53 at the crossroad between mitochondrial reactive oxygen species and necroptosis","volume":"207","author":"Rius-P\u00e9rez","year":"2023","journal-title":"Free. Radic. Biol. Med."},{"issue":"10-12","key":"10.1016\/j.critrevonc.2026.105462_bib125","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1089\/ars.2022.0209","article-title":"Mitochondrial Reactive Oxygen Species and Lytic Programmed Cell Death in Acute Inflammation","volume":"39","author":"Rius-P\u00e9rez","year":"2023","journal-title":"Antioxid. Redox Signal."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ccell.2018.03.022","article-title":"NRF2 and the Hallmarks of Cancer","volume":"34","author":"Rojo de la Vega","year":"2018","journal-title":"Cancer Cell."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib127","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.3892\/ol.2017.6059","article-title":"Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition","volume":"13","author":"Rong","year":"2017","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib128","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12943-025-02401-y","article-title":"Double vulnerability of active-NRF2 lung squamous cell carcinoma to NRF2 and TRIM24","volume":"24","author":"S\u00e1nchez-Ortega","year":"2025","journal-title":"Mol. Cancer"},{"issue":"23","key":"10.1016\/j.critrevonc.2026.105462_bib130","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1200\/JCO.23.01462","article-title":"Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma","volume":"42","author":"Sangro","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105462_bib131","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jtho.2021.08.010","article-title":"KEAP1 and TP53 Frame Genomic, Evolutionary, and Immunologic Subtypes of Lung Adenocarcinoma With Different Sensitivity to Immunotherapy","volume":"16","author":"Scalera","year":"2021","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1393213","article-title":"The global role of G6PD in infection and immunity","volume":"15","author":"Shah","year":"2024","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.critrevonc.2026.105462_bib133","doi-asserted-by":"crossref","first-page":"9095","DOI":"10.1158\/0008-5472.CAN-10-0384","article-title":"Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway","volume":"70","author":"Shibata","year":"2010","journal-title":"Cancer Res."},{"issue":"1-3","key":"10.1016\/j.critrevonc.2026.105462_bib134","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.cbi.2008.10.015","article-title":"AKR1C3 as a potential target for the inhibitory effect of dietary flavonoids","volume":"178","author":"Skarydov\u00e1","year":"2009","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib135","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging Mechanisms and Disease Relevance of Ferroptosis","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib136","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jare.2021.01.018","article-title":"Diagnosis and prognosis models for hepatocellular carcinoma patient's management based on tumor mutation burden","volume":"33","author":"Tang","year":"2021","journal-title":"J. Adv. Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105462_bib137","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12032-022-01808-7","article-title":"CD36 accelerates the progression of hepatocellular carcinoma by promoting FAs absorption","volume":"39","author":"Tao","year":"2022","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib138","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13105-025-01110-w","article-title":"The use of circulating miRNAs for the diagnosis, prognosis, and personalized treatment of MASLD","volume":"81","author":"Tobaruela-Resola","year":"2025","journal-title":"J. Physiol. Biochem."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105462_bib139","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global Epidemiology and Genetics of Hepatocellular Carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105462_bib140","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/S0024-3205(03)00566-6","article-title":"Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis","volume":"73","author":"Tsang","year":"2003","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105462_bib141","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2005.12.009","article-title":"Infection of human papillomavirus and overexpression of dihydrodiol dehydrogenase in uterine cervical cancer","volume":"102","author":"Ueda","year":"2006","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib142","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1248\/bpb.25.441","article-title":"Substrate specificity of human 3(20)alpha-hydroxysteroid dehydrogenase for neurosteroids and its inhibition by benzodiazepines","volume":"25","author":"Usami","year":"2002","journal-title":"Biol. Pharm. Bull."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib143","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/mc.20382","article-title":"Inducible nitric oxide synthase, nitrotyrosine and p53 mutations in the molecular pathogenesis of Barrett's esophagus and esophageal adenocarcinoma","volume":"47","author":"Vaninetti","year":"2008","journal-title":"Mol. Carcinog."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib144","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/FPC.0b013e32832c484b","article-title":"Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance","volume":"19","author":"Veitch","year":"2009","journal-title":"Pharm. Genom."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105462_bib145","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/ncb3380","article-title":"Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer","volume":"18","author":"Walerych","year":"2016","journal-title":"Nat. Cell. Biol."},{"issue":"24","key":"10.1016\/j.critrevonc.2026.105462_bib146","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.2174\/0113816128287535240429043610","article-title":"Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics","volume":"30","author":"Wan","year":"2024","journal-title":"Curr. Pharm. Des."},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105462_bib147","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/ijc.22402","article-title":"Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin","volume":"120","author":"Wang","year":"2007","journal-title":"Int. J. Cancer"},{"issue":"9-10","key":"10.1016\/j.critrevonc.2026.105462_bib148","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s10495-024-01995-w","article-title":"Resveratrol suppresses liver cancer progression by downregulating AKR1C3: targeting HCC with HSA nanomaterial as a carrier to enhance therapeutic efficacy","volume":"29","author":"Wang","year":"2024","journal-title":"Apoptosis"},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105462_bib149","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41418-022-00962-9","article-title":"Should mutant TP53 be targeted for cancer therapy?","volume":"29","author":"Wang","year":"2022","journal-title":"Cell. Death Differ."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105462_bib150","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/cdd.2013.111","article-title":"p53 talks to PARP: the increasing complexity of p53-induced cell death","volume":"20","author":"Wiman","year":"2013","journal-title":"Cell. Death Differ."},{"issue":"18","key":"10.1016\/j.critrevonc.2026.105462_bib151","doi-asserted-by":"crossref","first-page":"7681","DOI":"10.7150\/thno.74974","article-title":"AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy","volume":"12","author":"Wu","year":"2022","journal-title":"Theranostics"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.10.012","article-title":"DHDH-mediated D-xylose metabolism induces immune evasion in triple-negative breast cancer","volume":"6","author":"Wu","year":"2025","journal-title":"Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib153","doi-asserted-by":"crossref","DOI":"10.4251\/wjgo.v17.i3.98844","article-title":"Chlorogenic acid induces hepatocellular carcinoma cell ferroptosis via PTGS2\/AKR1C3\/GPX4 axis-mediated reprogramming of arachidonic acid metabolism","volume":"17","author":"Wu","year":"2025","journal-title":"World J. Gastrointest. Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105462_bib154","article-title":"Differential Yet Integral Contributions of Nrf1 and Nrf2 in the Human HepG2 Cells on Antioxidant Cytoprotective Response against Tert-Butylhydroquinone as a Pro-Oxidative Stressor","volume":"10","author":"Wufuer","year":"2021","journal-title":"Antioxid. (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105462_bib155","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jconrel.2021.09.034","article-title":"Biomimetic nanoparticles loading with gamabutolin-indomethacin for chemo\/photothermal therapy of cervical cancer and anti-inflammation","volume":"339","author":"Xiao","year":"2021","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105462_bib156","doi-asserted-by":"crossref","first-page":"7367","DOI":"10.1021\/acs.jmedchem.4c03035","article-title":"Discovery of Highly Potent AKR1C3 Inhibitors Treating Sorafenib-Resistant Hepatocellular Carcinoma","volume":"68","author":"Xing","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105462_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117413","article-title":"Discovery of highly potent AKR1Cs pan-inhibitors as chemotherapeutic potentiators to restore breast cancer drug resistance","volume":"289","author":"Xing","year":"2025","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105462_bib158","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27322","article-title":"LINC00540 promotes sorafenib resistance and functions as a ceRNA for miR-4677-3p to regulate AKR1C2 in hepatocellular carcinoma","volume":"10","author":"Xu","year":"2024","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib159","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.trecan.2021.09.003","article-title":"Necroptosis and tumor progression","volume":"8","author":"Yan","year":"2022","journal-title":"Trends Cancer"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib160","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.gpb.2013.04.001","article-title":"Quantitative Evaluation of Aldo\u2013Keto Reductase Expression in Hepatocellular Carcinoma (HCC) Cell Lines","volume":"11","author":"Yang","year":"2013","journal-title":"Genom. Proteom. & Bioinforma."},{"key":"10.1016\/j.critrevonc.2026.105462_bib161","doi-asserted-by":"crossref","DOI":"10.3892\/or.10.2.271","article-title":"Reduction of dihydrodiol dehydrogenase expression in resected hepatocellular carcinoma","author":"Yang","year":"2003","journal-title":"Oncol. Rep. 10(2) 271-276"},{"key":"10.1016\/j.critrevonc.2026.105462_bib162","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.2147\/CMAR.S316588","article-title":"Identification of a Prognostic Index Based on a Metabolic-Genomic Landscape Analysis of Hepatocellular Carcinoma (HCC)","volume":"13","author":"Yang","year":"2021","journal-title":"Cancer Manag. Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105462_bib163","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jcp.25349","article-title":"Mitochondria and Mitochondrial ROS in Cancer: Novel Targets for Anticancer Therapy","volume":"231","author":"Yang","year":"2016","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib164","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jjco\/hyac206","article-title":"Systematic review and meta-analysis of the efficacy of benzodiazepines for dyspnea in patients with cancer","volume":"53","author":"Yasuda","year":"2023","journal-title":"Jpn J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib165","first-page":"2026","article-title":"D-xylose suppresses hepatocellular carcinoma progression by regulating dihydrodiol dehydrogenase and remodeling the immune microenvironment","volume":"17","author":"Yu","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib166","article-title":"D-xylose suppresses hepatocellular carcinoma progression by regulating dihydrodiol dehydrogenase and remodeling the immune microenvironment","volume":"17","author":"Yu","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib167","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114986","article-title":"Baicalin enhances the efficacy of 5-Fluorouracil in gastric cancer by promoting ROS-mediated ferroptosis","volume":"164","author":"Yuan","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105462_bib168","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1080\/10408347.2020.1839736","article-title":"Polycyclic Aromatic Hydrocarbons: Occurrence, Electroanalysis, Challenges, and Future Outlooks","volume":"52","author":"Zainal","year":"2022","journal-title":"Crit. Rev. Anal. Chem."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105462_bib169","doi-asserted-by":"crossref","DOI":"10.3390\/biom11121841","article-title":"Flavonoids Synergistically Enhance the Anti-Glioblastoma Effects of Chemotherapeutic Drugs","volume":"11","author":"Zhai","year":"2021","journal-title":"Biomolecules"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105462_bib170","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41573-025-01145-0","article-title":"Thirty years of NRF2: advances and therapeutic challenges","volume":"24","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib171","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1186\/s13046-024-03161-1","article-title":"Two-polarized roles of transcription factor FOSB in lung cancer progression and prognosis: dependent on p53 status","volume":"43","author":"Zhang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105462_bib172","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.2147\/OTT.S321669","article-title":"TP53 Mutation Related and Directly Regulated lncRNA Prognosis Markers in Hepatocellular Carcinoma","volume":"14","author":"Zhang","year":"2021","journal-title":"Onco Targets Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105462_bib173","doi-asserted-by":"crossref","first-page":"87","DOI":"10.21037\/jgo-2025-aw-892","article-title":"Targeting AKR1C1 overcomes lenvatinib resistance in hepatocellular carcinoma through the STAT3-ABC transporters pathway","volume":"17","author":"Zhang","year":"2026","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib174","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.2147\/IJGM.S329031","article-title":"Evaluation of Ferroptosis-related Gene AKR1C1 as a Novel Biomarker Associated with the Immune Microenvironment and Prognosis in Breast Cancer","volume":"14","author":"Zhang","year":"2021","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.critrevonc.2026.105462_bib175","article-title":"Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma","volume":"12","author":"Zheng","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105462_bib176","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2025.07.047","article-title":"Astragalin induces immunogenic cell death in liver cancer by targeting NQO2 to promote ROS-mediated endoplasmic reticulum stress pathway","volume":"239","author":"Zheng","year":"2025","journal-title":"Free. Radic. Biol. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105462_bib177","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.apsb.2020.06.016","article-title":"SIRT6 as a key event linking P53 and NRF2 counteracts APAP-induced hepatotoxicity through inhibiting oxidative stress and promoting hepatocyte proliferation","volume":"11","author":"Zhou","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.critrevonc.2026.105462_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1481331","article-title":"Signature of immune-related metabolic genes predicts the prognosis of hepatocellular carcinoma","volume":"15","author":"Zhuo","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105462_bib179","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1152\/physrev.00026.2013","article-title":"Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release","volume":"94","author":"Zorov","year":"2014","journal-title":"Physiol. Rev."}],"updated-by":[{"DOI":"10.1016\/j.critrevonc.2026.105561","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000}},{"DOI":"10.1016\/j.critrevonc.2026.105561","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826003495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T02:51:14Z","timestamp":1787107874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826003495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":179,"alternative-id":["S1040842826003495"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105462","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opportunities and challenges of dihydrodiol dehydrogenase expression in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105462"}}